My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lexaria Bioscience Corp. - Common Stock
(NQ:
LEXX
)
0.8788
-0.0107 (-1.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lexaria Bioscience Corp. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
October 02, 2025
Via
Benzinga
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 29, 2025
Via
ACCESS Newswire
Keep an eye on the top gainers and losers in Friday's session.
September 26, 2025
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Lexaria Attending BIO International Convention
June 05, 2025
Via
ACCESS Newswire
Nasdaq Gains 100 Points; US Consumer Sentiment Falls
September 26, 2025
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.83% to 46,328.48 while the NASDAQ rose 0.45% to 22,484.92. The...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Friday's Intraday Session
September 26, 2025
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
Via
Benzinga
Which stocks are experiencing notable movement on Friday?
September 26, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Friday's session: gap up and gap down stocks
September 26, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Dow Jumps Over 250 Points; Fed's Key Inflation Gauge Remains Hot
September 26, 2025
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Friday. The Dow traded up 0.58% to 46,213.26 while the NASDAQ rose 0.31% to 22,455.17. The S&P 500 also...
Via
Benzinga
Topics
Economy
Stocks
What's going on in today's pre-market session
September 26, 2025
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via
Chartmill
Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 26, 2025
Via
ACCESS Newswire
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket
September 26, 2025
Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announced it entered into a sales contract with Walker Times International for the sale of 10,000 units of...
Via
Benzinga
Topics
Artificial Intelligence
Why Are Lexaria Bioscience Shares Soaring 45% After Hours?
September 26, 2025
Lexaria Bioscience Corp. (NASDAQ: LEXX) experienced a dramatic 45.10% surge in after-hours trading on Thursday, climbing to $2.22 from its closing price of $1.53.
Via
Benzinga
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
September 19, 2025
Via
ACCESS Newswire
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
August 27, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 27, 2025
Via
Benzinga
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
August 14, 2025
Via
ACCESS Newswire
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
August 06, 2025
Via
ACCESS Newswire
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study
July 28, 2025
Via
ACCESS Newswire
Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry
July 23, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
July 18, 2025
Via
Benzinga
Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide
June 23, 2025
Via
ACCESS Newswire
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
June 11, 2025
Via
ACCESS Newswire
Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company
May 12, 2025
Via
ACCESS Newswire
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock
April 28, 2025
Via
ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
April 25, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Top stock movements in today's session.
April 25, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss
April 25, 2025
Via
Benzinga
There are notable gap-ups and gap-downs in today's session.
April 25, 2025
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
These stocks that are showing activity before the opening bell on Friday.
April 25, 2025
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.